About Accel Research Sites
Accel Research Sites is a company based in Deland (United States) founded in 1998 was acquired by Alcanza Clinical Research in July 2023. Accel Research Sites offers products and services including Clinical Trial Platform and Patient Recruitment Service. Accel Research Sites operates in a competitive market with competitors including Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.
- Headquarter Deland, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Alcanza Clinical Research
& 1 more
-
Employee Count
Not available
-
Acquired by
Alcanza Clinical Research
(Jul 18, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accel Research Sites
Accel Research Sites offers a comprehensive portfolio of products and services, including Clinical Trial Platform and Patient Recruitment Service.
Platform for enrolling participants in medical research trials.
Service to match individuals with clinical trials for various conditions.
Funding Insights of Accel Research Sites
Investors in Accel Research Sites
Accel Research Sites has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Alcanza Clinical Research and C3 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital needs of small businesses are addressed by C3 Capital.
|
Locked | Locked | Locked | |
|
Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation
|
Locked | Locked | Locked |
Investor details for Accel Research Sites
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accel Research Sites
Investment portfolio details for Accel Research Sites
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accel Research Sites
Detailed financials for Accel Research Sites
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accel Research Sites Comparisons
Peer comparison for Accel Research Sites
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accel Research Sites
Accel Research Sites operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Cognivia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO focused on providing clinical trial supply services for biopharma sector
|
|
| Locked | Locked | Locked |
Direct-to-patient clinical trial solutions are provided by Lightship.
|
|
| Locked | Locked | Locked |
Specialty pharmaceutical company based on partnering model
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to support medical research initiatives.
|
|
| Locked | Locked | Locked |
Provider of data modeling and patient insights for clinical trial optimization
|
|
| Locked | Locked | Locked |
Clinical trial imaging workflow and data management technology is provided.
|
Detailed competitors of Accel Research Sites
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accel Research Sites
Complete news archive for Accel Research Sites
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accel Research Sites
Accel Research Sites was founded in 1998 and raised its 1st funding round 8 years after it was founded.
Accel Research Sites is headquartered in Deland, United States. It is registered at Deland, Florida, United States.
Accel Research Sites was founded in 1998 in DeLand, United States, within the healthcare sector. Clinical trials are conducted across multiple therapeutic areas to support pharmaceutical and biotechnology advancements. Services include patient recruitment, data management, and regulatory compliance. Operations are centered in Florida, with studies executed at dedicated research facilities to meet industry standards for safety and efficacy.
Accel Research Sites's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
Accel Research Sites offers Clinical Trial Platform and Patient Recruitment Service.
Accel Research Sites has 2 investors. Key investors include Alcanza Clinical Research, and C3 Capital.